Vaccine Stocks Surge Amid Positive Market Trends

Vaccine stocks Moderna, Novavax, and BioNTech rallied this week due to fears of an avian flu outbreak after cases were detected in the U.S. and Australia. Moderna and Pfizer/BioNTech are in talks with the U.S. government for a potential mRNA vaccine program, while Novavax is conducting a pre-clinical study. Despite the stock surge, the likelihood of a widespread avian flu outbreak remains low.